EUVIMEDEUVIMED entdecken
Crossref

Nicotinic Acetylcholine Receptors as Potential Tumor Biomarkers in Genitourinary Cancers: a Review Study

Khalil Hajiasgharzadeh, Behzad Baradaran, Leili Aghebati Maleki, Alireza Khabbazi

ImmunoAnalysis · 2021

DOI: 10.34172/ia.2021.04 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ImmunoAnalysis, 2021. Verfasst von Khalil Hajiasgharzadeh und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genitourinary tissues express the different subtypes of nicotinic acetylcholine receptors (nAChRs), which are involved in many physiologic and pathologic processes. New studies have indicated the significant role of nAChRs in multiple tumor-related properties in different types of malignancies. Genitourinary cancers (GUCs) represent a heterogeneous population of cancers, in both histology and approach to treatment. nAChRs are functionally expressed by a variety of immune cells, tumor cells, and tumor-associated cells in the microenvironment of GUCs. In the current review study, publications until May 2021 were included in the literature review to summarize the potential effects and clinical and experimental significance of nAChRs in GUCs pathogenesis. The results yielded substantial and some paradoxical evidence regard the role of different subtypes of nAChRs as potential regulators and predictive biomarkers for GUCs. The accumulated evidence demonstrated that nAChRs levels were increased in the GUCs samples, which provides clinically relevant information on utilizing nAChRs as a new biomarker to improve the prognosis of these cancers. Also, activation or blockade of these receptors may lead to different downstream signaling pathways and cause diverse effects. Regarding the significant global burden of GUCs, evaluation of these receptors and delineating their molecular mechanisms could enrich our understanding of the biology of GUCs and may have new opportunities for clinical impacts.

Zitieren

APA

Hajiasgharzadeh, K., Baradaran, B., Maleki, L. A., & Khabbazi, A. (2021). Nicotinic Acetylcholine Receptors as Potential Tumor Biomarkers in Genitourinary Cancers: a Review Study. ImmunoAnalysis. https://doi.org/10.34172/ia.2021.04

Vancouver

Hajiasgharzadeh K, Baradaran B, Maleki LA, Khabbazi A. Nicotinic Acetylcholine Receptors as Potential Tumor Biomarkers in Genitourinary Cancers: a Review Study. ImmunoAnalysis. 2021. doi:10.34172/ia.2021.04

BibTeX
@article{Hajiasgharzadeh2021,
  author = {Hajiasgharzadeh, Khalil and Baradaran, Behzad and Maleki, Leili Aghebati and Khabbazi, Alireza},
  title = {Nicotinic Acetylcholine Receptors as Potential Tumor Biomarkers in Genitourinary Cancers: a Review Study},
  journal = {ImmunoAnalysis},
  year = {2021},
  doi = {10.34172/ia.2021.04}
}
Kostenlos starten →